Drug Research
By Automating Traditional Methods, CROs Stand To Benefit
Big Pharma goes on to drive the demand for contract resource organizations- CROs by way of outsourcing almost 45% of research and development activities. It is well to be noted that the global biotechnology as well as pharmaceutical services...
Drug Research
Cresset Announces Global Collaboration with Enamine on New Virtual Screening Drug Discovery Technology
Cresset, an innovative provider of integrated in silico solutions for drug discovery announces a collaboration with Enamine, the world’s leading provider of chemical building blocks and drug discovery services to develop innovative new solutions for the early drug discovery...
Drug Research
Drug Discovery Gets A Novel Approach With Biology-Driven AI
The quite hectic journey so as to bring a single new drug to the market essentially spans a decade as well as costs an average of $2.6 billion. The AI as well as computing revolutions, however, happen to be...
Drug Research
Cancer Diagnostics Market Outlook 2031: Growth Trends and Insights
The global cancer diagnostics market, valued at USD 163.7 billion in 2021, is anticipated to witness substantial growth, reaching over USD 335.7 billion by 2031, with a projected compound annual growth rate (CAGR) of 7.4% from 2022 to 2031. Analysts...
Drug Research
New Levels Breached In Drug Discovery By Biology-Driven AI
The painstaking journey to bring one new drug to market almost spans a decade and costs an average of $2.6 billion. The AI as well as computing revolution, however, happens to be dynamically shifting the pharma industry, getting into...
Drug Research
Data-Driven Discoveries Get Powered By Lab Connectivity
Technology has gone on to change almost every aspect when it comes to the daily lives and has swiftly redefined the way one manages science. The digital disruption, which has been brought about by a massive influx of innovative...
Drug Research
Most Studied Diseases List Has Breast Cancer At The Top
Oncology research has gone on to attain priority status and has apparently been flush with pharma research dollars for years. The fact is that drug development companies went on to raise $7 billion in 2020 because of the disease’s...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read